Enanta Pharmaceuticals Inc Cash Flow Reinvestment Rate
Enanta Pharmaceuticals Inc cash flow reinvestment rate. Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Reinvestment Rate of 1.52x as of June 2025, reinvesting $26.64 Million (capex $155.00K plus investments $-26.48 Million) from operating cash flow of $17.51 Million. Explore Enanta Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Enanta Pharmaceuticals Inc (2011–2020)
Cash flow reinvestment rate of Enanta Pharmaceuticals Inc from 2011 to 2020. Historical reinvestment intensity for Enanta Pharmaceuticals Inc across 10 annual periods. Explore how much does Enanta Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Enanta Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2011–2020)
Enanta Pharmaceuticals Inc cash flow reinvestment rate by year from 2011 to 2020. Year-by-year capital reinvestment analysis for Enanta Pharmaceuticals Inc. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.21x | $22.72 Million | $7.09 Million | $1.45 Million | ▲ +164.2% |
| 2019 | 1.21x | $86.66 Million | $71.42 Million | $5.42 Million | ▼ -7.6% |
| 2018 | 1.31x | $38.38 Million | $29.22 Million | $2.98 Million | ▲ +1412.8% |
| 2017 | 0.09x | $4.57 Million | $52.65 Million | $2.51 Million | ▼ -92.9% |
| 2016 | 1.22x | $43.66 Million | $35.81 Million | $4.74 Million | ▲ +6.2% |
| 2015 | 1.15x | $88.02 Million | $76.67 Million | $2.34 Million | ▲ +808.5% |
| 2014 | 0.13x | $2.55 Million | $20.18 Million | $1.03 Million | ▼ -98.1% |
| 2013 | 6.50x | $69.22 Million | $10.65 Million | $606.00K | ▲ +58229.0% |
| 2012 | 0.01x | $252.00K | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $445.00K | $24.02 Million | $445.00K | — |